Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| NCT ID | NCT03697512 |
| Title | MALIBU Trial - Combination of Ibrutinib and Rituximab in Untreated Marginal Zone Lymphomas (MALIBU) |
| Acronym | MALIBU |
| Recruitment | Active, not recruiting |
| Gender | both |
| Phase | Phase II |
| Variant Requirements | No |
| Sponsors | International Extranodal Lymphoma Study Group (IELSG) |
| Indications | |
| Therapies | |
| Age Groups: | senior | adult |
| Covered Countries | ITA | FRA | CHE | BEL |